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LETTERS
Salmonella infection may be increased
by alterations in the gastrointestinal
tract, including decreased gastric acid-
ity and chronic gastrointestinal dis-
ease. Leukocytosis was noted in 25%
of patients. In fact, two thirds of the
patients had a normal leukocyte count
with immature leukocytes, which may
be attributable to their relatively
impaired cell-mediated immunity.
The predominant organism in this
series was S. Choleraesuis, followed
by S. Typhimurium. In Taiwan, the
rate of resistance of S. Choleraesuis to
ampicillin, chloramphenicol, or sul-
famethoxazole-trimethoprim increased
to approximately 90% for all 3 drugs
and the rate of resistance to
ciprofloxacin was from 7.7% to 59%
(5–7). The resistance rate of S.
Choleraesuis to ciprofloxacin in this
study was similar to our previous
report (7). 
Nine of the 11 patients who com-
pleted follow-up information received
appropriate antimicrobial drugs with
drainage; however, 4 died. These 4
deaths (57%) were due to S.
Choleraesuis-related empyema; 3
patients had underlying malignancy.
Although appropriate antimicrobial
drugs were used, our data suggest that
more aggressive treatment with open
drainage of the pleural effusion might
have contributed to a better outcome
than closed tube thoracostomy or sim-
ple thoracocentesis alone. In contrast
to S. Choleraesuis-related infection,
all 4 patients with non–S.
Choleraesuis-related thoracic empye-
ma survived. One of these patients did
not receive appropriate antimicrobial
drug treatment, but did have adequate
drainage with simple thoracocentesis.
This suggests adequate and aggres-
sive drainage of pleural effusion may
be as important as appropriate antimi-
crobial drugs. However, the overall
death rate (36%) in this study was still
higher than that of other reports (9).
This might have been due to the high
number of immunocompromised
patients in this study.
In conclusion, thoracic empyema
is a rare complication of nontyphoid
Salmonella infection and is closely
associated with an immunocompro-
mised condition, even in patients <65
years of age. Higher rates of resist-
ance and death were noted in patients
with empyema thoracic caused by S.
Choleraesuis. Early diagnosis, appro-
priate antimicrobial drug therapy, and
aggressive drainage are necessary to
improve the outcome of patients with
thoracic empyema due to S.
Choleraesuis.
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Asymptomatic
Yersinia pestis
Infection, China
To the Editor: Plague is one of the
oldest identifiable diseases. Modern
public health measures and effective
antimicrobial treatments have led to a
decrease in plague cases worldwide.
However, plague remains endemic in
many natural foci. Since the early
1990s, the World Health Organization
(WHO) has reported a steadily increas-
ing trend in human plague cases,
which has resulted in the recognition
of plague as a reemerging disease (1).
The emergence of antimicrobial drug–
resistant strains of Yersinia pestis,
along with an increasing number of
plague cases, remind us that plague
still poses a serious public health threat
(2,3). In China, human cases of plague
have been reported to WHO nearly
every year from 1989 to 2003; these
account for 9.5% of cases and 15.5%
of deaths from this disease in Asia (1).
Human cases of plague in China are
usually caused by contact with plague-
infected rodents. Here, we report the
results of a serologic survey by using 3
methods (passive hemagglutination
assay, Western blot, and protein
microarray analysis) in marmot
hunters in Qinghai Province, China.
One hundred twenty serum sam-
ples were collected in 2 villages in
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Huangyuan County, Qinghai Pro-
vince, from marmot hunters (63 sam-
ples) and their family members (57
samples); none had a history of fever
in the past 2 years. One hundred nine-
teen serum samples were collected
from persons with no history of mar-
mot hunting in 2 nearby counties in
Qinghai Province in which plague
was not endemic. Thirty serum sam-
ples were collected from persons in
Beijing and used as negative controls. 
All serum samples were initially
screened with a passive hemagglutina-
tion assay to detect immunoglobulin
(Ig) G antibody against F1 antigen of Y.
pestis, by using a standard protocol (4).
We then used an F1 antigen–based
Western blot to analyze all serum sam-
ples. The protein microarray analysis
was performed with 149 purified
recombinant proteins of Y. pestis (5). 
The results of the serologic survey
are summarized in the Table. The pas-
sive hemagglutination assay showed
17 positive samples in the marmot
hunter population. None of the control
serum samples were positive for F1
antigen in this assay. Western blot
identified 9 additional positive sam-
ples in the marmot hunter population,
resulting in a seropositivity rate of
21.7% (26/120). We also found posi-
tive samples in 4 (3.4%) of 119 serum
samples by using Western blot in per-
sons from areas in which plague was
not endemic. Identical results were
also obtained by using protein
microarray analysis, which validated
the results of Western blot.
Previous studies have shown that
plague antibodies were more preva-
lent in males in the exposed popula-
tion, and differences in the age, sex, or
ethnic group of plague patients are the
result of variations in exposure to the
pathogen, not intrinsic factors (6,7).
Our study showed that in the marmot
hunter population, the plague seropos-
itivity rate was significantly higher in
males (36.8%, 25/68) than in females
(2.0%, 1/52, p<0.01). Among the mar-
mot hunter population, 63 (92.6%) of
68 males were hunters. Plague anti-
bodies were also more prevalent in
marmot hunters (39.7%, 25/63) than
in their family members (1.8%, 1/57,
p<0.01). 
This is the first serologic survey of
plague in the marmot hunter popula-
tion. The plague seropositivity rate of
21.7% (26/120) in hunters and their
families is much higher than the 3.4%
(4/119) in the population from regions
in which plague was not endemic
(p<0.01). Seroprevalence in marmot
hunters was even higher (39.7%),
which suggests that marmot hunting
is a risk factor for plague infection.
The marmot (Marmota himala-
yana) is the main host of Y. pestis in
Qinghai Province. Plague-infected
marmots are more easily captured by
hunters. When persons hunt and butch-
er marmots without any effective pro-
tection, Y. pestis can be transmitted
through tiny wounds in the skin, by
bites of infected fleas, or by the respi-
ratory route. Asymptomatic plague
infection in marmot hunters might be
explained by prophylactic use of
antimicrobial drugs. Most hunters usu-
ally take sulfamethoxazole or tetracy-
cline as a prophylactic measure. Even
if the hunters were infected with Y.
pestis, they would likely not develop
symptomatic plague. However, if the
antimicrobial drugs are not effective or
hunters do not use prophylaxis, symp-
tomatic infections will occur. Most
reported human cases of plague in
Qinghai Province were caused by
hunting or butchering marmots, as
shown by a recent outbreak of plague
in October 2004 in Qinghai, in which
19 cases were reported and 8 persons
died (M. Li et al., unpub. data).
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Sporotrichosis,
Plain of Jars,
Lao People’s
Democratic
Republic 
To the Editor: In May 2003, a
previously healthy, 42-year-old rice
farmer and miller, living on the Plain
of Jars (Xieng Khuang Province) in
northeast Lao People’s Democratic
Republic (PDR) (Laos), dehusked and
polished glutinous rice in her hand-
operated rice mill. While milling, her
hand slipped, removing the skin cov-
ering the interpharyngeal joint of her
right index finger, on a dusty, wooden
part of the machine. She did not recall
the implantation of a wood splinter.
During the following 4 weeks, multi-
ple firm, erythematous lesions devel-
oped, which were not tender, fluctu-
ant, or itchy, at the site of the injury
and on the medial and anterior aspects
of the lower and upper arm (Figure).
The lesions spread proximally from
the site of injury, but they remained
confined to her right arm. She had no
fever, and no lymphadenopathy
developed. Her household had no
domestic animals, including cats. No
systemic disease developed, and she
showed no evidence of immunosup-
pression, diabetes, or alcoholism.
While waiting for a diagnosis, she
persuaded a surgeon to excise all the
lesions, but they soon recurred. She
believed that the only solution would
be to have her arm amputated. Initial
biopsy specimens demonstrated no
organisms and showed no growth on
Sabouraud dextrose agar. Without
facilities for further fungal diagnostic
work in Lao PDR, but with a probable
clinical diagnosis of sporotrichosis,
we sent one of the excised lesions to
Taiwan for molecular analysis by pre-
viously described methods (1,2).
Polymerase chain reaction (PCR) was
negative for mycobacteria but posi-
tive for Sporothrix schenckii, the
cause of sporotrichosis, and the diag-
nosis was confirmed by sequencing
the 18S rRNA gene, which showed
100% identity to that of S. schenckii
(1,2). The lesions resolved with 6
months of oral itraconazole therapy
(100 mg every 12 h). 
S. schenckii is a dimorphic fungus
found in soil, hay, decaying vegeta-
tion, and moss. Persons exposed to
these environmental foci, such as
farmers and gardeners, are especially
at risk. Percutaneous inoculation is
presumably the main method of infec-
tion, although inhalation and insect
and mammal bites and scratches, espe-
cially from armadillos and cats, have
been implicated (3,4). Our patient pre-
sumably contracted the fungus from
the wood frame of the milling
machine. In the 1940s, contamination
from untreated wood was responsible
for an epidemic that affected ≈3,000
gold miners in South Africa (from tim-
bers in the mine). Lymphocutaneous
sporotrichosis is the most frequent
presentation, and the traditional treat-
ments are oral saturated potassium
iodide solution and local hyperther-
mia, but oral itraconazole for 3 to 6
months is now recommended (3,4).
Sporotrichosis has been described
from North and South America,
Europe, and Japan. In Asia and
Australasia, it has been described
from India (5), Taiwan (1), Australia
(6), and Thailand (7), but apparently
not from Laos, Cambodia, and Burma
(Myanmar). Serologic evidence for
human sporotrichosis infection is
found in highland areas of southwest
Vietnam (8). At least in part, the rela-
tive paucity of reports probably
reflects the lack of sophisticated
fungal diagnostic techniques in much
of Southeast Asia. Some evidence
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Figure. Lesions on the right arm of the patient. 
